MYR Group (MYRG) Q3 2026 Earnings Call Transcript

MYR Group reported record Q3 2026 revenue of $1.26 billion, up 32.5% year over year, and record net income of $60.0 million, up 86.9%; diluted EPS rose 86.3% to $3.82. Gross margin increased 180 bps to 13.6%, and backlog reached a record $3.68 billion, up 38.2%. Management forecast 2027 revenue growth of 15%–18% and authorized a new $100 million share repurchase program, while operating cash flow fell to $46.1 million from $95.6 million and higher interest rates were cited as a headwind to payment terms.

Analysis

The earnings setup is positive, but the key distinction is between durable demand and repeatable earnings. C&I growth includes acquired businesses, while the quarter’s margin uplift benefited from favorable closeouts and productivity on projects nearing completion. That makes the reported margin a poor run-rate anchor: guidance, rather than Q3, is the more useful underwriting base. The main near-term risk is cash conversion. Longer payment terms, rising unbilled balances, and fixed-price exposure can absorb working capital even while EBITDA grows; if customers push payment terms further, MYRG may have to fund growth with cash before collections catch up. The $100 million buyback authorization offers flexibility, not evidence that shares are undervalued or that repurchases will occur. Over 6–18 months, prefab investment could partially offset field-labor constraints and support execution, while larger T&D project awards appear more consequential from late 2027 into 2028 than to the immediate growth outlook. That timing creates a risk that investors capitalize long-dated transmission demand too aggressively before awards convert to revenue. Relative to larger contractors such as Quanta Services, MYRG’s opportunity is execution and growth at smaller scale, but project closeouts and working-capital volatility warrant a quality discount until cash conversion improves.

Key Decisions for Investors

• Do not chase the initial earnings reaction without valuation context. Consider building a MYRG position on weakness, with the thesis anchored to the 2027 guidance range rather than extrapolating Q3 margins.
• Track quarterly operating cash flow against EBITDA, unbilled receivables and change-order approvals. If cash conversion stays weak as revenue expands, reduce exposure: persistent working-capital absorption would challenge the growth-to-equity-value conversion.
• Treat the 2028 T&D ramp as an event-driven watch item, not near-term earnings. Reassess after large awards become contracted backlog and verify start dates; delayed approvals or slippage would falsify the timing thesis.
• Risk controls: revisit the long thesis if C&I or T&D margins fall below their guided ranges, project inefficiencies recur, or payment-term changes materially worsen collections. Prefab productivity and closeout-related margin gains should be validated in subsequent quarters.